Search Results - "Malcolmson, Richard"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Physical Characterization of Tobramycin Inhalation Powder: I. Rational Design of a Stable Engineered-Particle Formulation for Delivery to the Lungs by Miller, Danforth P, Tan, Trixie, Tarara, Thomas E, Nakamura, John, Malcolmson, Richard J, Weers, Jeffry G

    Published in Molecular pharmaceutics (03-08-2015)
    “…A spray-dried engineered particle formulation, Tobramycin Inhalation Powder (TIP), was designed through rational selection of formulation composition and…”
    Get full text
    Journal Article
  2. 2

    Physical Characterization of Tobramycin Inhalation Powder: II. State Diagram of an Amorphous Engineered Particle Formulation by Miller, Danforth P, Tan, Trixie, Nakamura, John, Malcolmson, Richard J, Tarara, Thomas E, Weers, Jeffry G

    Published in Molecular pharmaceutics (05-06-2017)
    “…Tobramycin Inhalation Powder (TIP) is a spray-dried engineered particle formulation used in TOBI Podhaler, a drug-device combination for treatment of cystic…”
    Get full text
    Journal Article
  3. 3

    Dry powder formulations for pulmonary delivery by Malcolmson, Richard J, Embleton, Jonathan K

    Published in Pharmaceutical Science & Technology Today (01-12-1998)
    “…This review examines the key issues surrounding the development and preparation of formulations for dry powder inhalers. The various inhaler devices that are…”
    Get full text
    Book Review Journal Article
  4. 4

    Inhalation of tobramycin using simulated cystic fibrosis patient profiles by Haynes, Alfred, Geller, David, Weers, Jeffry, Ament, Brian, Pavkov, Richard, Malcolmson, Richard, Debonnett, Laurie, Mastoridis, Paul, Yadao, Anthony, Heuerding, Silvia

    Published in Pediatric pulmonology (01-11-2016)
    “…Summary Introduction TOBI® Podhaler™ is a capsule‐based drug‐device combination (tobramycin inhalation powder [TIP] 28 mg capsules via unit‐dose dry powder…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Novel Toxicology Program to Support the Development of Inhaled VentaProst by Tepper, Jeffrey, Pfeiffer, Juergen, Bujold, Kim, Fink, James B., Malcolmson, Richard, Sullivan, Dennis, Authier, Simon, Entcheva-Dimitrov, Plamena, Clark, Andrew

    Published in International journal of toxicology (01-09-2020)
    “…Currently, off-label continuous administration of inhaled epoprostenol is used to manage hemodynamics during mitral valve surgery. A toxicology program was…”
    Get full text
    Journal Article
  7. 7

    Idealhalers Versus Realhalers: Is It Possible to Bypass Deposition in the Upper Respiratory Tract? by Weers, Jeffry G, Son, Yoen-Ju, Glusker, Mark, Haynes, Alfred, Huang, Daniel, Kadrichu, Nani, Le, John, Li, Xue, Malcolmson, Richard, Miller, Danforth P, Tarara, Thomas E, Ung, Keith, Clark, Andy

    “…This review discusses how advances in formulation and device design can be utilized to dramatically improve lung targeting and dose consistency relative to…”
    Get more information
    Journal Article
  8. 8
  9. 9
  10. 10

    Foreign particles testing in orally inhaled and nasal drug products by Blanchard, James, Coleman, James, Hayling, Claire D'Abreu, Ghaderi, Raouf, Haeberlin, Barbara, Hart, John, Jensen, Steen, Malcolmson, Richard, Mittelman, Stanley, Nagao, Lee M, Sekulic, Sonja, Snodgrass-Pilla, Caesar, Sundahl, Mikael, Thompson, Glenn, Wolff, Ronald

    Published in Pharmaceutical research (01-12-2004)
    “…The International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS) presents this paper in order to contribute to public discussion…”
    Get full text
    Journal Article
  11. 11
  12. 12

    The use of small volume ocular sprays to improve the bioavailability of topically applied ophthalmic drugs by Martini, Luigi G., Embleton, Jonathan K., Malcolmson, Richard J., Wilson, Clive G.

    “…It is accepted that the standard eyedrop volume of 25–50 μl is too large to be accommodated within the conjunctival sac, leading to overspill and to rapid…”
    Get full text
    Journal Article
  13. 13